Das Krankenhaus Buchholz in der Nordheide ist ein Akutkrankenhaus in öffentlicher Trägerschaft mit 304 Betten in Buchholz in der Nordheide im niedersächsischen Landkreis Harburg. Es ist akademisches Lehrkrankenhaus der Universität Hamburg und der polnischen Universität Rzeszow.

During the past decade, Krankenhaus Buchholz conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Buchholz" #1 sponsor was "IHF GmbH - Institut für Herzinfarktforschung" with 2 trials, followed by "Cagent Vascular LLC" with 1 trials sponsored, "GWT-TUD GmbH" with 1 trials sponsored, "University Hospital Schleswig-Holstein" with 1 trials sponsored and "Veryan Medical Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Buchholz" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "ClinStat GmbH" with 1 trials as a collaborator and "University of Luebeck" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Buchholz" are "Peripheral Arterial Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Antithrombotic Therapy" (1 trials), "Breast Cancer After Breast Conserving Surgery Indicating Postoperative Radiotherapy With Boost" (1 trials) and "Chronic Kidney Disease (CKD)" (1 trials). Many other conditions were trialed in "Krankenhaus Buchholz" in a lesser frequency.

Most popular intervention types in "Krankenhaus Buchholz" are "Device" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB Scaffold" (1 trials), "BioMimics 3D Stent" (1 trials), "Hypofractionation with simultaneous integrated boost" (1 trials) and "Serranator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Buchholz" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Krankenhaus Buchholz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Krankenhaus Buchholz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Buchholz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".